Germline variation and risk of immune-related adverse events (irAEs): A real-world BioVU study.
Justin M. Balko, Lydia Yao, Siwei Zhang, Catherine C. Fahey, Alexandra M. Haugh, Andrea L. Davis, Eric Mukherjee, Christian Hammer, Elizabeth J. Phillips, Adrian Bejan, Yaomin Xu, Douglas B. Johnson (2024). Germline variation and risk of immune-related adverse events (irAEs): A real-world BioVU study.. Journal of Clinical Oncology, 42(16_suppl), pp. 10582-10582, DOI: 10.1200/jco.2024.42.16_suppl.10582.
